MedTrace Logo

Pharmacist-Administered Injections for Contraception

NCT00775047 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2008-10-17

No results posted yet for this study

Summary

The purpose of this study is to see if it is a feasible arrangement to have women receive their second and third birth control injection (with Depo-Provera) at a pharmacy compared with receiving it a Planned Parenthood Clinic. Compliance with returning for injections as well as patient satisfaction with the method, providers, and location where injection was received will be assessed and compared between the two sites. The hypothesis is that there will be no difference in return rates for injections at either the pharmacy or the clinic site.

Conditions

  • Contraception

Interventions

OTHER

Pharmacist-administered

women will receive their injections at a pharmacy by a clinical pharmacist

OTHER

clinic-administered injections

women will return for their injections to the clinic where recruitment took place. They will receive one at 3 months and 6 months.

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Carla Picardo, MD, MPH · Dept. of Social Medicine, University of North Carolina

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2007-09-30
Completion
2008-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00775047 on ClinicalTrials.gov